These findings indicate a possible role for nesfatin-1 in metabolic dysregulation in PCOS and underscore its potential as a biomarker, although additional large-scale and longitudinal studies are needed to confirm these observations. This evidence concerns the gene NUCB2 and polycystic ovary syndrome.